DNA METHYLATION LANDSCAPE AS A POTENTIAL PLAYER IN ACQUIRED-DRUG RESISTANCE IN OVARIAN CANCER

被引：0

作者：

Silva, Romina ^{[1
,2
,3
]}

Glennon, Kate ^{[4
]}

Metoudi, Michael ^{[5
]}

Moran, Bruce ^{[6
]}

Salta, Sofia ^{[7
]}

Slattery, Karen ^{[8
]}

Treacy, Ann ^{[9
]}

Martin, Terri ^{[10
]}

Shaw, Jacqui ^{[11
]}

Doran, Peter ^{[10
]}

Lynch, Lydia ^{[12
]}

Jeronimo, Carmen ^{[7
,13
]}

Perry, Antoinette ^{[1
,3
]}

Brennan, Donal ^{[14
]}

机构：

[1] Univ Coll Dublin, Canc Biol & Therapeut Lab, Dublin, Ireland

[2] Univ Coll Duvlin, Ucd Sch Med, Dublin, Ireland

[3] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin, Ireland

[4] Mater Hosp, Gynaecol Oncol, Dublin D RWY, Ireland

[5] Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland

[6] St Vincents Univ Hosp, Dept Pathol, Dublin, Ireland

[7] Portuguese Oncol Inst Porto, Canc Biol Epigenet Grp, IPO Porto, Porto Comprehens Canc Ctr Porto CCC, Porto, Portugal

[8] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland

[9] Mater Hosp, Dept Pathol, Dublin, Ireland

[10] Mater Misericordiae Univ Hosp, Clin Res Ctr, Dublin, Ireland

[11] Univ Leicester, Leicester Canc Res Ctr, Leicester, England

[12] Trinity Coll Dublin, Trin Biomed Sci Inst, Dublin, Ireland

[13] Inst Biomed Sci Abel Salazar, Dept Pathol & Mol Immunol, Porto, Portugal

[14] Univ Coll Dublin, Ucd Sch Med, Mater Hosp, Gynaecol Oncol Grp, Dublin, Ireland

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2022年 / 32卷

关键词：

D O I：

10.1136/ijgc-2022-igcs.95

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP004/#741

引用

页码：A49 / A49

页数：1

共 50 条

[1] Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
C Zeller
W Dai
N L Steele
A Siddiq
A J Walley
C S M Wilhelm-Benartzi
S Rizzo
A van der Zee
J A Plumb
R Brown
Oncogene, 2012, 31 : 4567 - 4576
[2] Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
Zeller, C.
Dai, W.
Steele, N. L.
Siddiq, A.
Walley, A. J.
Wilhelm-Benartzi, C. S. M.
Rizzo, S.
van der Zee, A.
Plumb, J. A.
Brown, R.
ONCOGENE, 2012, 31 (42) : 4567 - 4576
[3] Drug-induced DNA hypermethylation: A potential mediator of acquired drug resistance during cancer chemotherapy
Nyce, JW
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 1997, 386 (02) : 153 - 161
[4] The DNA methylation landscape in cancer
Skvortsova, Ksenia
Stirzaker, Clare
Taberlay, Phillippa
DNA METHYLATION, 2019, 63 (06): : 797 - 811
[5] DNA methylation in ovarian cancer
Strathdee, G
Appleton, K
Plumb, J
Brown, R
BRITISH JOURNAL OF CANCER, 2001, 85 : 18 - 18
[6] DNA methylation and ovarian cancer
Ahluwalia, A
Yan, P
Hurteau, JA
Bigsby, RM
Jung, SH
Huang, THM
Nephew, KP
GYNECOLOGIC ONCOLOGY, 2001, 82 (02) : 261 - 268
[7] DNA methylation in ovarian cancer
Koukoura, Ourania
Daponte, Alexandros
Sifakis, Stavros
Spandidos, Demetrios A.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 : S61 - S61
[8] Alterations in DNA methylation - An important player in cancer
Baylin, SB
JOURNAL OF PATHOLOGY, 2001, 193 : 12A - 12A
[9] Aberrant DNA methylation in ovarian cancer is there an epigenetic predisposition to drug response?
Wei, SH
Brown, R
Huang, THM
EPIGENETICS IN CANCER PREVENTION: EARLY DETECTION AND RISK ASSESSMENT, 2003, 983 : 243 - 250
[10] DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer
Lund, Riikka J.
Huhtinen, Kaisa
Salmi, Jussi
Rantala, Juha
Nguyen, Elizabeth V.
Moulder, Robert
Goodlett, David R.
Lahesmaa, Riitta
Carpen, Olli
SCIENTIFIC REPORTS, 2017, 7

← 1 2 3 4 5 →